Literature DB >> 32697938

Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response.

Hayley A McNamara1, Azza H Idris2, Henry J Sutton1, Rachel Vistein2, Barbara J Flynn2, Yeping Cai1, Kevin Wiehe3, Kirsten E Lyke4, Deepyan Chatterjee1, Natasha Kc5, Sumana Chakravarty5, B Kim Lee Sim5, Stephen L Hoffman5, Mattia Bonsignori3, Robert A Seder2, Ian A Cockburn6.   

Abstract

Generating sufficient antibody to block infection is a key challenge for vaccines against malaria. Here, we show that antibody titers to a key target, the repeat region of the Plasmodium falciparum circumsporozoite protein (PfCSP), plateaued after two immunizations in a clinical trial of the radiation-attenuated sporozoite vaccine. To understand the mechanisms limiting vaccine responsiveness, we developed immunoglobulin (Ig)-knockin mice with elevated numbers of PfCSP-binding B cells. We determined that recall responses were inhibited by antibody feedback, potentially via epitope masking of the immunodominant PfCSP repeat region. Importantly, the amount of antibody that prevents boosting is below the amount of antibody required for protection. Finally, while antibody feedback limited responses to the PfCSP repeat region in vaccinated volunteers, potentially protective subdominant responses to PfCSP C-terminal regions expanded with subsequent boosts. These data suggest that antibody feedback drives the diversification of immune responses and that vaccination for malaria will require targeting multiple antigens.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cells; Ig-knockin mice; Plasmodium falciparum; antibody; antibody feedback; malaria; vaccines

Mesh:

Substances:

Year:  2020        PMID: 32697938     DOI: 10.1016/j.chom.2020.07.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  20 in total

1.  Analysis of gene expression profiles to study malaria vaccine dose efficacy and immune response modulation.

Authors:  Supantha Dey; Harpreet Kaur; Mohit Mazumder; Elia Brodsky
Journal:  Genomics Inform       Date:  2022-09-30

2.  Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain.

Authors:  Leerang Yang; Matthew Van Beek; Zijun Wang; Frauke Muecksch; Marie Canis; Theodora Hatziioannou; Paul D Bieniasz; Michel C Nussenzweig; Arup K Chakraborty
Journal:  bioRxiv       Date:  2022-08-25

3.  Antigenic imprinting in SARS-CoV-2.

Authors:  S Momsen Reincke; Harald Prüss; Ian A Wilson; Jakob Kreye
Journal:  Clin Transl Med       Date:  2022-07

4.  Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies.

Authors:  Sven Kratochvil; Chen-Hsiang Shen; Ying-Cing Lin; Kai Xu; Usha Nair; Lais Da Silva Pereira; Prabhanshu Tripathi; Johan Arnold; Gwo-Yu Chuang; Eleonora Melzi; Arne Schön; Baoshan Zhang; Marlon Dillon; Brian Bonilla; Barbara J Flynn; Kathrin H Kirsch; Neville K Kisalu; Patience K Kiyuka; Tracy Liu; Li Ou; Marie Pancera; Reda Rawi; Mateo Reveiz; Kareen Seignon; Lawrence T Wang; Michael T Waring; John Warner; Yongping Yang; Joseph R Francica; Azza H Idris; Robert A Seder; Peter D Kwong; Facundo D Batista
Journal:  Immunity       Date:  2021-11-16       Impact factor: 43.474

Review 5.  Anti-malarial humoral immunity: the long and short of it.

Authors:  Kai J Rogers; Rahul Vijay; Noah S Butler
Journal:  Microbes Infect       Date:  2021-03-05       Impact factor: 2.700

6.  A Point Mutation in IKAROS ZF1 Causes a B Cell Deficiency in Mice.

Authors:  Brigette Boast; Lisa A Miosge; Hye Sun Kuehn; Vicky Cho; Vicki Athanasopoulos; Hayley A McNamara; Yovina Sontani; Yan Mei; Debbie Howard; Henry J Sutton; Sofia A Omari; Zhijia Yu; Mariam Nasreen; T Daniel Andrews; Ian A Cockburn; Christopher C Goodnow; Sergio D Rosenzweig; Anselm Enders
Journal:  J Immunol       Date:  2021-03-03       Impact factor: 5.422

7.  Splenic Dendritic Cells and Macrophages Drive B Cells to Adopt a Plasmablast Cell Fate.

Authors:  Hayley A McNamara; Mireille H Lahoud; Yeping Cai; Jessica Durrant-Whyte; James H O'Connor; Irina Caminschi; Ian A Cockburn
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786

8.  Unwanted Feedback: Malaria Antibodies Hinder Vaccine Boosting.

Authors:  Camila H Coelho; Patrick E Duffy
Journal:  Cell Host Microbe       Date:  2020-10-07       Impact factor: 21.023

9.  Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.

Authors:  Saya Moriyama; Yu Adachi; Takashi Sato; Keisuke Tonouchi; Lin Sun; Shuetsu Fukushi; Souichi Yamada; Hitomi Kinoshita; Kiyoko Nojima; Takayuki Kanno; Minoru Tobiume; Keita Ishijima; Yudai Kuroda; Eun-Sil Park; Taishi Onodera; Takayuki Matsumura; Tomohiro Takano; Kazutaka Terahara; Masanori Isogawa; Ayae Nishiyama; Ai Kawana-Tachikawa; Masaharu Shinkai; Natsuo Tachikawa; Shigeki Nakamura; Takahiro Okai; Kazu Okuma; Tetsuro Matano; Tsuguto Fujimoto; Ken Maeda; Makoto Ohnishi; Takaji Wakita; Tadaki Suzuki; Yoshimasa Takahashi
Journal:  Immunity       Date:  2021-07-02       Impact factor: 31.745

Review 10.  B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.

Authors:  Jenna J Guthmiller; Henry A Utset; Patrick C Wilson
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.